Welcome to LookChem.com Sign In|Join Free

CAS

  • or

65141-45-9

65141-45-9

Post Buying Request

65141-45-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65141-45-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 65141-45-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,1,4 and 1 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 65141-45:
(7*6)+(6*5)+(5*1)+(4*4)+(3*1)+(2*4)+(1*5)=109
109 % 10 = 9
So 65141-45-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H9N3O4.ClH/c12-8(7-2-1-3-9-6-7)10-4-5-15-11(13)14;/h1-3,6H,4-5H2,(H,10,12);1H

65141-45-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(pyridine-3-carbonylamino)ethyl nitrate,hydrochloride

1.2 Other means of identification

Product number -
Other names N-(2-(Nitrooxy)ethyl)nicotinamide HCl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65141-45-9 SDS

65141-45-9Downstream Products

65141-45-9Relevant articles and documents

THERAPEUTIC COMBINATIONS

-

Paragraph 0524, (2020/08/25)

Methods of treatment include administering effective amounts of a nitrogen oxide (NO) donor (such as nicorandil) and a hydrogen sulfide (H2S) releasing agent (such as zofenopril) to a subject in need thereof. In various embodiments, the H2S releasing agent is administered in an amount that is effective to enhance the therapeutic efficacy of the NO donor. Coformulations of the H2S releasing agent and the NO donor are provided that are suitable for treating a number of conditions. In various embodiments, treatments for conditions such as chronic kidney disease, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, familial dilated cardiomyopathy and/or idiopathic dilated cardiomyopathy are provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 65141-45-9